{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:18:50Z","timestamp":1778602730576,"version":"3.51.4"},"reference-count":63,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,12]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Little is known about the long-term health and well-being of older (\u226560 years) patients who received blood or marrow transplant (BMT), a growing population at risk for late-occurring morbidity and mortality. This study included \u22652-year survivors (N=1581) who underwent BMT between 1990 and 2014 at age \u226560 years. Severe\/life-threatening and fatal chronic health conditions were identified using Common Terminology Criteria for Adverse Events. Multivariable regression analysis compared the risk of severe\/life-threatening health conditions and health status between survivors and 594 age-matched sibling controls. Standardized mortality ratios (SMRs) and, for subsequent malignant neoplasms, standardized incidence ratios (SIRs) were calculated and compared with the general population. The prevalence of severe\/life-threatening conditions was 72% in survivors of BMT vs 51% in siblings (P&amp;lt; .001), yielding 2.9-fold higher odds of severe\/life-threatening conditions (95% confidence interval [CI], 2.2-3.7) among the survivors. Survivors were more likely to report poor general health (odds ratio [OR], 4.1 [95%CI, 2.8-6.0]), functional impairment (OR, 3.2 [95%CI, 2.5-4.0]), activity limitation (OR, 3.1 [95%CI, 2.4-3.9]), and frailty (OR, 3.5 [95% CI, 2.1-6.0]). Among survivors, the overall SMR was 5.3 (95%CI, 5.0-5.6). There was an especially high risk of infection-related mortality (SMR=35.2 [95%CI, 30.3-40.6]). Survivors had a 3.8-fold risk of subsequent neoplasms (95%CI, 3.5-4.2) relative to the general population, with incidence rates highest for Hodgkin lymphoma (SIR=18.5 [95%CI, 7.4-37.5]) and melanoma (SIR=7.4 [95%CI, 5.1-10.2]). Older recipients of BMT have a high burden of severe\/life-threatening conditions and poor health status compared with sibling controls, contributing to increased relative risk of premature mortality. These findings emphasize the ongoing health care burden of survivors of BMT, particularly in this older population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025018477","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T22:07:00Z","timestamp":1771970820000},"page":"2951-2961","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Long-term health outcomes in older recipients of blood or marrow transplantation: a report from the BMTSS"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2069-1518","authenticated-orcid":false,"given":"Rusha","family":"Bhandari","sequence":"first","affiliation":[{"name":"1Department of Population Sciences, City of Hope, Duarte, CA"},{"name":"2Department of Pediatrics, City of Hope, Duarte, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingrui","family":"Meng","sequence":"additional","affiliation":[{"name":"3Institute for Cancer Outcomes and Survivorship, The University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsey","family":"Hageman","sequence":"additional","affiliation":[{"name":"3Institute for Cancer Outcomes and Survivorship, The University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liton","family":"Francisco","sequence":"additional","affiliation":[{"name":"3Institute for Cancer Outcomes and Survivorship, The University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth Schlichting","family":"Ross","sequence":"additional","affiliation":[{"name":"3Institute for Cancer Outcomes and Survivorship, The University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8371-8821","authenticated-orcid":false,"given":"Nora","family":"Balas","sequence":"additional","affiliation":[{"name":"3Institute for Cancer Outcomes and Survivorship, The University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0662-5699","authenticated-orcid":false,"given":"Alysia","family":"Bosworth","sequence":"additional","affiliation":[{"name":"1Department of Population Sciences, City of Hope, Duarte, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Bhatia","sequence":"additional","affiliation":[{"name":"4Division of Hematology, Oncology and Bone Marrow Transplantation, The University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3319-5652","authenticated-orcid":false,"given":"Wendy","family":"Landier","sequence":"additional","affiliation":[{"name":"3Institute for Cancer Outcomes and Survivorship, The University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8078-8579","authenticated-orcid":false,"given":"Daniel J.","family":"Weisdorf","sequence":"additional","affiliation":[{"name":"5Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4333-5017","authenticated-orcid":false,"given":"F. Lennie","family":"Wong","sequence":"additional","affiliation":[{"name":"1Department of Population Sciences, City of Hope, Duarte, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7755-5683","authenticated-orcid":false,"given":"Smita","family":"Bhatia","sequence":"additional","affiliation":[{"name":"3Institute for Cancer Outcomes and Survivorship, The University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2604-8603","authenticated-orcid":false,"given":"Saro H.","family":"Armenian","sequence":"additional","affiliation":[{"name":"1Department of Population Sciences, City of Hope, Duarte, CA"},{"name":"2Department of Pediatrics, City of Hope, Duarte, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"issue":"9","key":"2026051211562736900_bib1","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1182\/blood-2017-03-772368","article-title":"Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States","volume":"130","author":"Muffly","year":"2017","journal-title":"Blood"},{"issue":"8","key":"2026051211562736900_bib2","first-page":"505","article-title":"Current activity trends and outcomes in hematopoietic cell transplantation and cellular therapy - a report from the CIBMTR","volume":"31","author":"Spellman","year":"2025","journal-title":"Transpl Cell Ther"},{"issue":"5","key":"2026051211562736900_bib3","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/bmt.2015.241","article-title":"Process of allogeneic hematopoietic cell transplantation decision making for older adults","volume":"51","author":"Randall","year":"2016","journal-title":"Bone Marrow Transpl"},{"issue":"8","key":"2026051211562736900_bib4","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/sj.bmt.1705108","article-title":"Characteristics and correlates of cognitive functioning following bone marrow transplantation","volume":"36","author":"Booth-Jones","year":"2005","journal-title":"Bone Marrow Transpl"},{"issue":"1","key":"2026051211562736900_bib5","doi-asserted-by":"crossref","first-page":"101243","DOI":"10.1016\/j.beha.2021.101243","article-title":"How old is too old for a transplant?","volume":"34","author":"Weisdorf","year":"2021","journal-title":"Best Pract Res Clin Haematol"},{"issue":"11","key":"2026051211562736900_bib6","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/jnci\/djaa022","article-title":"Conditional survival, cause-specific mortality, and risk factors of late mortality after allogeneic hematopoietic cell transplantation","volume":"112","author":"Wong","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"2026051211562736900_bib7","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.bbmt.2019.12.766","article-title":"Outcomes of allogeneic stem cell transplant for elderly patients with hematologic malignancies","volume":"26","author":"Hsu","year":"2020","journal-title":"Biol Blood Marrow Transpl"},{"issue":"28","key":"2026051211562736900_bib8","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1200\/JCO.2014.60.4777","article-title":"Outcomes of nonmyeloablative HLA-haploidentical blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in older adults","volume":"33","author":"Kasamon","year":"2015","journal-title":"J Clin Oncol"},{"issue":"17","key":"2026051211562736900_bib9","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1182\/blood-2009-06-229369","article-title":"Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study","volume":"116","author":"Sun","year":"2010","journal-title":"Blood"},{"key":"2026051211562736900_bib10","unstructured":"National Cancer Institute\n          . Common Terminology Criteria for Adverse Events (CTCAE). Accessed 2 March 2026. https:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03\/CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pdf."},{"issue":"5","key":"2026051211562736900_bib11","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1200\/JCO.2014.57.4863","article-title":"Age-dependent changes in health status in the Childhood Cancer Survivor cohort","volume":"33","author":"Hudson","year":"2015","journal-title":"J Clin Oncol"},{"issue":"3","key":"2026051211562736900_bib12","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"10","key":"2026051211562736900_bib13","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1001\/jamaoncol.2016.0855","article-title":"Physiologic frailty in nonelderly hematopoietic cell transplantation patients: results from the bone marrow transplant survivor study","volume":"2","author":"Arora","year":"2016","journal-title":"JAMA Oncol"},{"issue":"3","key":"2026051211562736900_bib14","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1200\/JCO.19.01226","article-title":"Prevalence and predictors of frailty in childhood cancer survivors and siblings: a report from the childhood cancer survivor study","volume":"38","author":"Hayek","year":"2020","journal-title":"J Clin Oncol"},{"issue":"11","key":"2026051211562736900_bib15","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/sj.bmt.1702419","article-title":"Validation of self-reported complications by bone marrow transplantation survivors","volume":"25","author":"Louie","year":"2000","journal-title":"Bone Marrow Transpl"},{"issue":"7","key":"2026051211562736900_bib16","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.bbmt.2013.04.002","article-title":"Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study","volume":"19","author":"Sun","year":"2013","journal-title":"Biol Blood Marrow Transpl"},{"issue":"28","key":"2026051211562736900_bib17","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1200\/JCO.21.02829","article-title":"Burden of long-term morbidity borne by survivors of acute myeloid leukemia treated with blood or marrow transplantation: the results of the BMT survivor study","volume":"40","author":"Armenian","year":"2022","journal-title":"J Clin Oncol"},{"issue":"18","key":"2026051211562736900_bib18","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1200\/JCO.21.02372","article-title":"Trends in late mortality and life expectancy after autologous blood or marrow transplantation over three decades: a BMTSS report","volume":"40","author":"Bhatia","year":"2022","journal-title":"J Clin Oncol"},{"issue":"7","key":"2026051211562736900_bib19","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/s41375-024-02238-2","article-title":"Pre-frailty after blood or marrow transplantation and the risk of subsequent mortality","volume":"38","author":"Balas","year":"2024","journal-title":"Leukemia"},{"key":"2026051211562736900_bib20","unstructured":"Centers for Disease Control and Prevention\n          . Compressed Mortality File on CDC WONDER. Accessed 2 March 2026. https:\/\/wonder.cdc.gov\/mortsql.html."},{"issue":"2","key":"2026051211562736900_bib21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/oxfordjournals.aje.a113306","article-title":"A shortcut method for calculating the 95 per cent confidence interval of the standardized mortality ratio","volume":"115","author":"Vandenbroucke","year":"1982","journal-title":"Am J Epidemiol"},{"key":"2026051211562736900_bib22","first-page":"14","article-title":"The% NEWSURV family of macros: an update on the survival plotting macro% NEWSURV and an introduction to expansion macros","author":"Meyers","year":"2017","journal-title":"Pharma SUG"},{"issue":"24","key":"2026051211562736900_bib23","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1200\/JCO.2008.16.1000","article-title":"Analysis of survival by tumor response and other comparisons of time-to-event by outcome variables","volume":"26","author":"Anderson","year":"2008","journal-title":"J Clin Oncol"},{"issue":"3","key":"2026051211562736900_bib24","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/CIRCOUTCOMES.110.957951","article-title":"Landmark analysis at the 25-year landmark point","volume":"4","author":"Dafni","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026051211562736900_bib25","unstructured":"National Cancer Institute\n          . How to Request Access to SEER Data. Accessed 2 March 2026. https:\/\/seer.cancer.gov\/data\/access.html."},{"issue":"7","key":"2026051211562736900_bib26","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/bimj.4710350716","article-title":"Confidence intervals for the mean of a Poisson distribution: a review","volume":"35","author":"Sahai","year":"1993","journal-title":"Biometrical J"},{"issue":"1","key":"2026051211562736900_bib27","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1182\/hematology.2021000257","article-title":"Allogeneic hematopoietic cell transplantation for older patients","volume":"2021","author":"Lin","year":"2021","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"4","key":"2026051211562736900_bib28","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.cell.2014.10.039","article-title":"Geroscience: linking aging to chronic disease","volume":"159","author":"Kennedy","year":"2014","journal-title":"Cell"},{"issue":"11","key":"2026051211562736900_bib29","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1001\/jamaoncol.2021.3676","article-title":"Trends in late mortality and life expectancy after allogeneic blood or marrow transplantation over 4 decades: a blood or marrow transplant survivor study report","volume":"7","author":"Bhatia","year":"2021","journal-title":"JAMA Oncol"},{"issue":"5","key":"2026051211562736900_bib30","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/leu.2012.311","article-title":"Conditional survival and cause-specific mortality after autologous hematopoietic cell transplantation for hematological malignancies","volume":"27","author":"Vanderwalde","year":"2013","journal-title":"Leukemia"},{"issue":"1","key":"2026051211562736900_bib31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41409-020-01001-2","article-title":"Geriatric syndromes in 2-year, progression-free survivors among older recipients of allogeneic hematopoietic cell transplantation","volume":"56","author":"Lin","year":"2021","journal-title":"Bone Marrow Transpl"},{"issue":"34","key":"2026051211562736900_bib32","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1200\/JCO.19.00129","article-title":"Chemotherapy and risk of subsequent malignant neoplasms in the childhood cancer survivor study cohort","volume":"37","author":"Turcotte","year":"2019","journal-title":"J Clin Oncol"},{"issue":"21","key":"2026051211562736900_bib33","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1200\/JCO.2017.76.7764","article-title":"Risk, risk factors, and surveillance of subsequent malignant neoplasms in survivors of childhood cancer: a review","volume":"36","author":"Turcotte","year":"2018","journal-title":"J Clin Oncol"},{"issue":"25","key":"2026051211562736900_bib34","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1200\/JCO.20.00231","article-title":"Total body irradiation and risk of breast cancer after blood or marrow transplantation: a blood or marrow transplantation survivor study report","volume":"38","author":"McDonald","year":"2020","journal-title":"J Clin Oncol"},{"issue":"1","key":"2026051211562736900_bib35","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41408-024-01122-7","article-title":"Increased risk of subsequent neoplasm after hematopoietic stem cell transplantation in 5-year survivors of childhood acute lymphoblastic leukemia","volume":"14","author":"Westerveld","year":"2024","journal-title":"Blood Cancer J"},{"key":"2026051211562736900_bib36","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.14694\/EdBook_AM.2014.34.e57","article-title":"The rising incidence of second cancers: patterns of occurrence and identification of risk factors for children and adults","author":"Morton","year":"2014","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"4","key":"2026051211562736900_bib37","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1470-2045(11)70061-4","article-title":"Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries","volume":"12","author":"Berrington de Gonzalez","year":"2011","journal-title":"Lancet Oncol"},{"issue":"3","key":"2026051211562736900_bib38","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jamadermatol.2024.5129","article-title":"Incidence of and risk factors for cutaneous malignant neoplasms after blood or marrow transplant","volume":"161","author":"Broman","year":"2025","journal-title":"JAMA Dermatol"},{"issue":"5","key":"2026051211562736900_bib39","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/s41409-020-01147-z","article-title":"Secondary oral cancer following hematopoietic cell transplantation","volume":"56","author":"Santarone","year":"2021","journal-title":"Bone Marrow Transpl"},{"issue":"9","key":"2026051211562736900_bib40","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1182\/blood.2021010764","article-title":"What's new in the pathogenesis and treatment of therapy-related myeloid neoplasms","volume":"138","author":"Voso","year":"2021","journal-title":"Blood"},{"issue":"8","key":"2026051211562736900_bib41","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1158\/1078-0432.CCR-22-2598","article-title":"CHIP happens: clonal hematopoiesis of indeterminate potential and its relationship to solid tumors","volume":"29","author":"Reed","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"22","key":"2026051211562736900_bib42","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1182\/blood-2018-03-840629","article-title":"Detection of clonal hematopoiesis of indeterminate potential in clinical sequencing of solid tumor specimens","volume":"131","author":"Severson","year":"2018","journal-title":"Blood"},{"key":"2026051211562736900_bib43","doi-asserted-by":"crossref","first-page":"105126","DOI":"10.1016\/j.ebiom.2024.105126","article-title":"Impact of ambient air pollution on colorectal cancer risk and survival: insights from a prospective cohort and epigenetic Mendelian randomization study","volume":"103","author":"Jiang","year":"2024","journal-title":"EBioMedicine"},{"issue":"4","key":"2026051211562736900_bib44","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/cncr.34575","article-title":"Severe, life-threatening, and fatal chronic health conditions after allogeneic blood or marrow transplantation in childhood","volume":"129","author":"Holmqvist","year":"2023","journal-title":"Cancer"},{"issue":"14","key":"2026051211562736900_bib45","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1200\/JCO.2016.71.6712","article-title":"Clonal hematopoiesis associated with adverse outcomes after autologous stem-cell transplantation for lymphoma","volume":"35","author":"Gibson","year":"2017","journal-title":"J Clin Oncol"},{"issue":"1","key":"2026051211562736900_bib46","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1001\/jamacardio.2023.4105","article-title":"Clonal hematopoiesis and cardiovascular disease in patients with multiple myeloma undergoing hematopoietic cell transplant","volume":"9","author":"Rhee","year":"2024","journal-title":"JAMA Cardiol"},{"issue":"6","key":"2026051211562736900_bib47","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.3390\/ijms25063319","article-title":"Accelerated aging in cancer survivors: cellular senescence, frailty, and possible opportunities for interventions","volume":"25","author":"Wang","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2026051211562736900_bib48","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12872-025-04567-1","article-title":"Interacting and joint effects of frailty and inflammation on cardiovascular disease risk and the mediating role of inflammation in middle-aged and elderly populations","volume":"25","author":"Xu","year":"2025","journal-title":"BMC Cardiovasc Disord"},{"key":"2026051211562736900_bib49","doi-asserted-by":"crossref","first-page":"111055","DOI":"10.1016\/j.exger.2020.111055","article-title":"Inflammation as a risk factor for the development of frailty in the Lothian Birth Cohort 1936","volume":"139","author":"Welstead","year":"2020","journal-title":"Exp Gerontol"},{"issue":"1","key":"2026051211562736900_bib50","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1186\/s13063-022-06848-y","article-title":"Telehealth exercise to improve physical function and frailty in patients with multiple myeloma treated with autologous hematopoietic Stem cell transplantation (TIPS): protocol of a randomized controlled trial","volume":"23","author":"Lee","year":"2022","journal-title":"Trials"},{"issue":"1","key":"2026051211562736900_bib51","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1186\/s12885-023-10884-5","article-title":"Feasibility of implementing a supervised telehealth exercise intervention in frail survivors of hematopoietic cell transplantation: a pilot randomized trial","volume":"23","author":"Lee","year":"2023","journal-title":"BMC Cancer"},{"issue":"8","key":"2026051211562736900_bib52","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/PHM.0000000000002428","article-title":"Role of outpatient physical medicine and rehabilitation in a multidisciplinary prehabilitation program for older adults before allogeneic hematopoietic stem cell transplant","volume":"103","author":"Cheng","year":"2024","journal-title":"Am J Phys Med Rehabil"},{"issue":"1","key":"2026051211562736900_bib53","doi-asserted-by":"crossref","first-page":"e002936","DOI":"10.1136\/bmjoq-2024-002936","article-title":"Real-world evaluation of physiotherapist-led exercise prehabilitation and rehabilitation during autologous stem cell transplantation in myeloma: a single-centre experience","volume":"14","author":"Land","year":"2025","journal-title":"BMJ Open Qual"},{"issue":"2","key":"2026051211562736900_bib54","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1200\/JOP.2017.026435","article-title":"What every oncologist should know about geriatric assessment for older patients with cancer: young international society of geriatric oncology position paper","volume":"14","author":"Loh","year":"2018","journal-title":"J Oncol Pract"},{"issue":"18","key":"2026051211562736900_bib55","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1002\/cncr.35390","article-title":"The association between social vulnerability and geriatric assessment impairments among older adults with gastrointestinal cancers-The CARE Registry","volume":"130","author":"Fowler","year":"2024","journal-title":"Cancer"},{"issue":"25","key":"2026051211562736900_bib56","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1182\/blood.2024027543","article-title":"Social determinants of health and access to allogeneic hematopoietic cell transplantation for acute myeloid leukemia","volume":"145","author":"Wuliji","year":"2025","journal-title":"Blood"},{"issue":"11","key":"2026051211562736900_bib57","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/jnci\/djac150","article-title":"Social vulnerability and risk of nonrelapse mortality after allogeneic hematopoietic cell transplantation","volume":"114","author":"Bhandari","year":"2022","journal-title":"J Natl Cancer Inst"},{"issue":"13","key":"2026051211562736900_bib58","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1182\/bloodadvances.2025015793","article-title":"Novel composite health assessment risk model for older allogeneic transplant recipients: BMT-CTN 1704","volume":"9","author":"Sorror","year":"2025","journal-title":"Blood Adv"},{"issue":"4","key":"2026051211562736900_bib59","first-page":"415.e1","article-title":"Preconditioning frailty phenotype influences survival and relapse for older allogeneic transplantation recipients","volume":"30","author":"Sung","year":"2024","journal-title":"Transpl Cell Ther"},{"issue":"8","key":"2026051211562736900_bib60","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1182\/blood-2015-04-639831","article-title":"Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia","volume":"126","author":"Ciurea","year":"2015","journal-title":"Blood"},{"issue":"22","key":"2026051211562736900_bib61","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1182\/bloodadvances.2019000790","article-title":"Results from a multidisciplinary clinic guided by geriatric assessment before stem cell transplantation in older adults","volume":"3","author":"Derman","year":"2019","journal-title":"Blood Adv"},{"issue":"2","key":"2026051211562736900_bib62","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11899-024-00725-y","article-title":"Transplantation and cellular therapy for older adults-the MSK approach","volume":"19","author":"Lin","year":"2024","journal-title":"Curr Hematol Malig Rep"},{"issue":"1","key":"2026051211562736900_bib63","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11899-021-00646-0","article-title":"Multidisciplinary approach to older adults with hematologic malignancies-a paradigm shift","volume":"17","author":"Wall","year":"2022","journal-title":"Curr Hematol Malig Rep"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/9\/2951\/2515733\/blooda_adv-2025-018477-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/9\/2951\/2515733\/blooda_adv-2025-018477-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:56:43Z","timestamp":1778601403000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/9\/2951\/566830\/Long-term-health-outcomes-in-older-recipients-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":63,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,5,12]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025018477","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5,12]]},"published":{"date-parts":[[2026,4,29]]}}}